Skip to content
Screener

Roivant Sciences ROIV Bermuda — Total deferred tax benefit

Other geography segments

Switzerland
$0
United States
$0

Similar metrics at other companies

Lesaka Technologies, Inc. logo
LSAKUS — Deferred Income Tax Expense Benefit
-$2.53M
Lesaka Technologies, Inc. logo
LSAKZA — Deferred Income Tax Expense Benefit
-$3.45M-409%
Wave Life Sciences logo
WVESG — Deferred Income Tax Expense Benefit
$0
Novanta logo
NOVTUS — Deferred Income Tax Expense Benefit
-$1.28M+59.4%
Ovintiv logo
OVVCA — Deferred Income Tax Expense Benefit
$100M+3,233%
Ovintiv logo
OVVUS — Deferred Income Tax Expense Benefit
-$39M-162%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:17 AM EDT
Fiscal year
FY2025
Accession
0001635088-26-000061
Current taxes: / BermudaYears Ended March 31, 2026 / $Years Ended March 31, 2026 / —Years Ended March 31, 2025 / $Years Ended March 31, 2025 / —Years Ended March 31, 2024 / $Years Ended March 31, 2024 / —
Other(27)(310)
Total current tax expense$$133,329$$48,174$$21,503
Deferred taxes:
Bermuda$$$
United States
Switzerland
Other
Total deferred tax benefit$$$

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Roivant Sciences's bermuda — total deferred tax benefit?
Roivant Sciences (ROIV) reported bermuda — total deferred tax benefit of $0 in Q1 2026.
What does bermuda — total deferred tax benefit mean?
This metric represents the reduction in future income tax expense resulting from temporary differences between the financial reporting and tax reporting bases of assets and liabilities within the Bermuda segment. It indicates a non-cash tax advantage that is expected to lower future tax payments. Analysts track this to evaluate the impact of tax accounting timing differences on the segment's long-term financial position.

Ask your AI about Roivant Sciences's bermuda — total deferred tax benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude